Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (938)	9/20/1999 2:01:00 PM
From: Bo Didley	Respond to of 5582

OCTOBER...NOVEMBER...DECEMBER...Looking forward to it ! ``The cold category is a $2.3 billion business at retail. When you have a product with ZICAM's potential, it's mandatory to partner with a team of experts who understand how to sell OTC and packaged goods in new and creative ways.' The agency, with significant experience in launching traditional packaged goods products, plans on going beyond the typical media buy for a packaged good product. ``To help introduce a product that has the potential to turn the traditional cold symptom remedy market upside down is a once in a lifetime opportunity,' said Lee Kovel, Creative Director. ``We are thrilled to tackle this groundbreaking product. Expect to see some guerrilla tactics and media usage that would probably make a traditional brand manager faint.' biz.yahoo.com OCTOBER-- another upcoming news release !! biz.yahoo.com

To: Street Walker who wrote (938)	9/20/1999 7:37:00 PM
From: big run	Read Replies (1) \| Respond to of 5582

Dude....I believe you're wrong on a few issues here.... 5.6 million Float But it will behave like it has 1.6 million float (the effective float) because ~4 million of the float is held by long term holders who have extremely high price targets in the long term and have no plans to sell. This same factor attributed to KIDE's success as an investment. Where did you get this information??? And how do you know that ~4 million of the float is held by long term holders who have extremely high price targets in the long term and have no plans to sell. Since there is no way that I know of to determine this I'd really like to know. Personally, I think you're blowing smoke out of your butt. And the next paragraph.... Each time the float is recycled the support level rises. As the effective float is recycled there will be shareholders who will simply not sell. Which means the effective float decreases while demand increases. ....is also BS. Why??? Would the same hold true for a stock declining??? Hell no!!! I've studied alot on float turnover and such and if this were true we'd all simply trade the float patterns. Next paragraph..... Because it is the most effective cold remedy, its the one people will buy. ZICAM will claim a growing chunk of the $2.3 Billion spent on remedies year after year.....think long term. GUMM is an IRA type, long term investment you will not want to sell. And people bought Cold-Eeze, too. But, things not being what they always seem, they just couldn't cut the mustard.